Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can glue and barbed sutures beat staples for joint surgery wounds?

NCT ID NCT07749495

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether closing surgical wounds with barbed sutures and skin glue leads to better healing than traditional staples or monofilament sutures in people undergoing hip or knee replacement. About 400 adults will be randomly assigned to one of the closure methods, and the main goal is to see if the wound heals without complications like infection, bleeding, or opening within the first two weeks after surgery. The study also looks at scar appearance and severity of any wound issues.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
barbed sutures and skin glue
What this could lead to
If effective, this technique could reduce wound complications and improve scar appearance after joint replacement, potentially becoming a preferred closure method.
What could go wrong
This is a comparative study, not a cure. Results may vary by patient, and the technique might not show significant benefits over standard methods. Risks include infection or wound healing issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women aged over 18 years * Patient who has provided written informed consent in duplicate * Patient scheduled for a primary hip or knee prosthesis implantation * BMI \< 30 kg/m² * Non-smoker or smoking cessation for more than 4 weeks * Patient able to read and understand French * Patient with sufficient cognitive capacity to strictly follow study instructions (completion of the calendar) Exclusion Criteria: * Patient expresses opposition to participating in the study * Patients under 18 years of age * Patient scheduled for prosthesis revision surgery * History of osteoarticular or soft-tissue infection * Diabetes, cardiovascular disease, immunodeficiency, or immunosuppressive treatment * Consumption of drugs, tobacco, or alcohol * Allergy to nickel (staples) or adhesive * History of anxiety disorders (generalized anxiety disorder, panic disorder, specific phobia, agoraphobia, social anxiety, separation anxiety), obsessive compulsive disorder (OCD), or post-traumatic stress disorder (PTSD) * Patient unable to read and/or understand French * Individuals deprived of liberty by judicial or administrative decision * Adults unable to consent or incapable of expressing consent * Subjects not affiliated with or not benefiting from a social security scheme * Pregnant or breastfeeding women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip arthroplasty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Surgical Wound

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.